Found: 463
Select item for more details and to access through your institution.
Improved Sleep Quality Improves Blood Pressure Control among Patients with Chronic Kidney Disease: A Pilot Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Intradialytic Hypotension: Is Midodrine the Answer?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Antihypertensive agents, insulin sensitivity, and new-onset diabetes.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Hypertension and chest pain: Expect the expected.
- Published in:
- Patient Care (Print), 1995, v. 29, n. 13, p. 175
- By:
- Publication type:
- Article
Management of Hypertension in the Elderly Population.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2012, v. 67, n. 12, p. 1343, doi. 10.1093/gerona/gls148
- By:
- Publication type:
- Article
Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
- Published in:
- American Journal of Hypertension, 2024, v. 37, n. 6, p. 438, doi. 10.1093/ajh/hpae020
- By:
- Publication type:
- Article
Efficacy and Safety of Ocedurenone: Subgroup Analysis of the BLOCK-CKD Study.
- Published in:
- American Journal of Hypertension, 2023, v. 36, n. 11, p. 612, doi. 10.1093/ajh/hpad066
- By:
- Publication type:
- Article
Novel Therapies on the Horizon of Hypertension Management.
- Published in:
- American Journal of Hypertension, 2023, v. 36, n. 2, p. 73, doi. 10.1093/ajh/hpac111
- By:
- Publication type:
- Article
A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease: The International Verapamil-Trandolapril Study (INVEST): A Randomized Controlled Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 290, n. 21, p. 2805, doi. 10.1001/jama.290.21.2805
- By:
- Publication type:
- Article
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 19, p. 2560, doi. 10.1001/jama.289.19.2560
- By:
- Publication type:
- Article
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease: Results From the AASK Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2002, v. 288, n. 19, p. 2421, doi. 10.1001/jama.288.19.2421
- By:
- Publication type:
- Article
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Acute Interstitial Nephritis with Glomerulopathy Due to Nonsteroidal Anti-Inflammatory Agents: A Review of Its Clinical Spectrum and Effects of Steroid Therapy.
- Published in:
- 1990
- By:
- Publication type:
- Other
The Effects of Enalapril on Urinary Protein Excretion in Patients with Idiopathic Membranous Nephropathy.
- Published in:
- 1990
- By:
- Publication type:
- Other
Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone—Translational Aspects and Clinical Perspectives across Multiple Organ Systems.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 16, p. 9243, doi. 10.3390/ijms23169243
- By:
- Publication type:
- Article
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 9, p. 2041, doi. 10.1093/ndt/gfad009
- By:
- Publication type:
- Article
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE).
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 4, p. 894, doi. 10.1093/ndt/gfac198
- By:
- Publication type:
- Article
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 2, p. 372, doi. 10.1093/ndt/gfac157
- By:
- Publication type:
- Article
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 7, p. 1261, doi. 10.1093/ndt/gfab336
- By:
- Publication type:
- Article
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 6, p. 1014, doi. 10.1093/ndt/gfaa294
- By:
- Publication type:
- Article
Major adverse renal events (MARE): a proposal to unify renal endpoints.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 3, p. 491, doi. 10.1093/ndt/gfz212
- By:
- Publication type:
- Article
The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 7, p. 1277, doi. 10.1093/ndt/gfy311
- By:
- Publication type:
- Article
association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.
- Published in:
- Nephrology Dialysis Transplantation, 2019, v. 34, n. 3, p. 515, doi. 10.1093/ndt/gfy247
- By:
- Publication type:
- Article
Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial.
- Published in:
- Journal of Diabetes Research, 2022, p. 1, doi. 10.1155/2022/9998891
- By:
- Publication type:
- Article
Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockers.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 8, p. 757, doi. 10.1111/j.1463-1326.2009.01052.x
- By:
- Publication type:
- Article
Risk factor assessment for new onset diabetes: literature review.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 3, p. 177, doi. 10.1111/j.1463-1326.2008.00925.x
- By:
- Publication type:
- Article
Angiotensin--converting Enzyme Inhibitors and Progression of Diabetic Nephropathy.
- Published in:
- Annals of Internal Medicine, 1993, v. 118, n. 8, p. 643, doi. 10.7326/0003-4819-118-8-199304150-00013
- By:
- Publication type:
- Article
Effects of different calcium antagonists on proteinuria associated with diabetes mellitus.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus.
- Published in:
- 1990
- By:
- Publication type:
- journal article
The author replies.
- Published in:
- 2013
- By:
- Publication type:
- Letter
The Author Replies:.
- Published in:
- Kidney International, 2013, v. 84, n. 1, p. 215, doi. 10.1038/ki.2013.125
- By:
- Publication type:
- Article
The OSCAR for cardiovascular disease prevention in chronic kidney disease goes to blood pressure control.
- Published in:
- Kidney International, 2013, v. 83, n. 1, p. 20, doi. 10.1038/ki.2012.364
- By:
- Publication type:
- Article
Renal outcomes in hypertensive Black patients at high cardiovascular risk.
- Published in:
- Kidney International, 2012, v. 81, n. 6, p. 568, doi. 10.1038/ki.2011.417
- By:
- Publication type:
- Article
National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events.
- Published in:
- Kidney International, 2010, v. 78, n. 8, p. 726, doi. 10.1038/ki.2010.292
- By:
- Publication type:
- Article
Dual RAAS blockade is desirable in kidney disease: Con.
- Published in:
- Kidney International, 2010, v. 78, n. 6, p. 546, doi. 10.1038/ki.2010.226
- By:
- Publication type:
- Article
Prehypertension: is it relevant for nephrologists?
- Published in:
- Kidney International, 2010, v. 77, n. 3, p. 194, doi. 10.1038/ki.2009.439
- By:
- Publication type:
- Article
Response to ‘Inhibiting renal sodium–glucose transport in diabetes: pass the salt’.
- Published in:
- 2009
- By:
- Publication type:
- Letter
The Management of Hypertension in 2018: What Should the Targets Be?
- Published in:
- Current Hypertension Reports, 2019, v. 21, n. 6, p. 1, doi. 10.1007/s11906-019-0946-7
- By:
- Publication type:
- Article
Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis.
- Published in:
- Current Hypertension Reports, 2019, v. 21, n. 2, p. N.PAG, doi. 10.1007/s11906-019-0920-4
- By:
- Publication type:
- Article
Renal Denervation: a Field in Flux.
- Published in:
- Current Hypertension Reports, 2016, v. 18, n. 7, p. 1, doi. 10.1007/s11906-016-0666-1
- By:
- Publication type:
- Article
Pulmonary scar carcinoma. A clinicopathologic analysis.
- Published in:
- 1983
- By:
- Publication type:
- journal article
Mineralocorticoid receptor antagonists and reno‐protection: What's the evidence & where do they fit? A guide for non‐specialists.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, p. 33, doi. 10.1111/dom.15617
- By:
- Publication type:
- Article
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3530, doi. 10.1111/dom.15685
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta‐analysis and meta‐regression.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2209, doi. 10.1111/dom.15529
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. C1, doi. 10.1111/dom.15423
- By:
- Publication type:
- Article
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 191, doi. 10.1111/dom.15305
- By:
- Publication type:
- Article
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3327, doi. 10.1111/dom.15232
- By:
- Publication type:
- Article
The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2151, doi. 10.1111/dom.15091
- By:
- Publication type:
- Article